| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbdfa36b677f4ef61245ca725011e221 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 |
| filingDate |
2018-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdf116a204c4f477e4352d6f8296f7ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7b3a3243c548dbdf4c8f13cb9909efa |
| publicationDate |
2019-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2019131480-A |
| titleOfInvention |
Transdermal absorption enhancer and transdermal preparation |
| abstract |
[PROBLEMS] To provide a preparation having a balance between skin permeability and low skin irritation. A transdermal absorption enhancer comprising at least one salt selected from the group consisting of choline-isostearate, guanidine-oleate and guanidine-isostearate, and tricaprylin. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022045163-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112274496-A |
| priorityDate |
2018-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |